K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 310.05 INR 1.29% Market Closed
Market Cap: 5B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Tax Provision
-â‚ą59.2m
CAGR 3-Years
-39%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Tax Provision
-â‚ą16.7B
CAGR 3-Years
-28%
CAGR 5-Years
-26%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Tax Provision
-â‚ą16.5B
CAGR 3-Years
-20%
CAGR 5-Years
-21%
CAGR 10-Years
-16%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Tax Provision
-â‚ą17B
CAGR 3-Years
-24%
CAGR 5-Years
-21%
CAGR 10-Years
-8%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Tax Provision
-â‚ą7.8B
CAGR 3-Years
-22%
CAGR 5-Years
-40%
CAGR 10-Years
-13%
M
Mankind Pharma Ltd
NSE:MANKIND
Tax Provision
-â‚ą4.6B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Kilitch Drugs (India) Ltd
Glance View

Market Cap
5B INR
Industry
Pharmaceuticals

Kilitch Drugs (India) Ltd. engages in the manufacture and sale of pharmaceuticals, medicinal chemical, and botanical products. The company is headquartered in Mumbai, Maharashtra. The company is primarily engaged in the development, manufacturing, and marketing of finished dosages. The Company’s products include parenteral solutions, effervescent, nutritional products, and medical device. Its products categories include urinary alkalizer, cephalosporins products, gastroenterology, non steroidal anti-inflammatory drugs (NSAIDs), anticonvulsant/antiepileptic, adrenergic agonist, neurotonic, muscle relaxant/stimulant, aminoglycosides, anti-infective, anti-inflammatory, anti-malarials, anti-hypertensive, anaesthetic, uterine stimulants. Its parenteral solutions include neurotonic, veterinary products, metered nasal drops, vaccines, oncology, and ophthalmic products. Its effervescent products include Roipar, Duregra, And Roivit. The firm offers nutritional products, such as Celtine. The firm also offers medical devices, such as C-Seal.

KILITCH Intrinsic Value
285 INR
Overvaluation 8%
Intrinsic Value
Price
K

See Also

What is Kilitch Drugs (India) Ltd's Tax Provision?
Tax Provision
-59.2m INR

Based on the financial report for Jun 30, 2024, Kilitch Drugs (India) Ltd's Tax Provision amounts to -59.2m INR.

What is Kilitch Drugs (India) Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
-9%

Over the last year, the Tax Provision growth was -49%. The average annual Tax Provision growth rates for Kilitch Drugs (India) Ltd have been -39% over the past three years , -9% over the past five years .

Back to Top